From: Graves’ disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature
Parameter | Observed | Reference range |
---|---|---|
Serum characteristics | ||
CRP, mg/dL | 0.1 | < 0.3 |
ESR (1 h), mm | 13 | 3–15 |
FT3, pmol/L | 33.2 | 3.8–6.3 |
FT4, pmol/L | 72.1 | 11.6–19.3 |
TSH, mIU/L | < 0.01 | 0.08–0.54 |
TRAb, IU/L | 5.0 | < 2.0 |
TSAb, % | 262 | < 120 |
Tg-Ab, IU/mL | 0.9 | < 4.1 |
TPO-Ab, IU/mL | 2.2 | < 5.6 |
Tg, ng/mL | 121 | < 34 |